Journal
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Volume 297, Issue 1, Pages E1-E9Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpendo.90926.2008
Keywords
acyl-coenzyme A: cholesterol acyltransferase inhibitors; atherosclerosis; Alzheimer's disease
Categories
Funding
- National Heart, Lung, and Blood Institute [HL-60306, HL-36705]
- Ministry of Science and Technology of China [2006CB910600]
Ask authors/readers for more resources
Chang TY, Li BL, Chang CC, Urano Y. Acyl-coenzyme A: cholesterol acyltransferases. Am J Physiol Endocrinol Metab 297: E1-E9, 2009. First published January 13, 2009; doi:10.1152/ajpendo.90926.2008.-The enzymes acylcoenzyme A (CoA): cholesterol acyltransferases (ACATs) are membrane-bound proteins that utilize long-chain fatty acyl-CoA and cholesterol as substrates to form cholesteryl esters. In mammals, two isoenzymes, ACAT1 and ACAT2, encoded by two different genes, exist. ACATs play important roles in cellular cholesterol homeostasis in various tissues. This chapter summarizes the current knowledge on ACAT-related research in two areas: 1) ACAT genes and proteins and 2) ACAT enzymes as drug targets for atherosclerosis and for Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available